Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT06257875 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06257875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 23, 2024
Completion date
September 30, 2027
Enrollment
156 (actual)
Sites
191

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis